Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 12, 1997

View Archived Issues

Focus on Alzheimer's disease research in the U.S.

Focus on diabetes research in the U.S.

Drug discovery technology pioneered at Oncogene Science now patented

Essential tremor gene located by Icelandic genomics company

Annual Report: Daiichi Pharmaceutical

Heparinase gene covered by U.S., European patents

Gliatech cleared to begin U.S. clinical trials of third ADCON product

Regressin induces apoptosis and direct inhibition of tumor cell growth

T Cell Sciences recipient of SBIR grant to develop atherosclerosis model

Clinical studies begin with BNP-7787

Biricodar dicitrate enters phase II studies in ovarian cancer

RWJ-63556: dual COX-2/5-LO inhibitor effective in canine model of local inflammation

Vertex, Kissei to collaborate on MAP kinase inhibitors

New clinical study on Multikine initiated in Canada

L-374087: a new thrombin inhibitor developed at Merck & Co.

HER-2/neu gene amplification useful in predicting outcome in endometrial cancer

DuPont Merck presents dual MMP/TNF-alpha-converting enzyme inhibitor

Myocardial protective effects of Hoe-642 evaluated in porcine hearts

Sano's combination patch shows promise for smoking cessation

Clinical results reported for protease inhibitor/nucleoside analogue combination

Kampo medicine with hypolipidemic and antiatherosclerotic effects

In vitro and in vivo antibacterial activity of two herbal medicines

Capases: a new target for neurodegenerative disease therapy

Cannabinoid receptor ligand shows synergistic hematopoietic effects in vitro

Pivotal data reported for ENBREL in severe RA

New trinem reported by SRI

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 11, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...